Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Man Killed in Crash on Van Buren Boulevard


4 Vehicles Involved in Fatal Jurupa Valley Accident

Fatal Accident 3

Jurupa Valley, CA (January 9, 2020) – A man was killed in a multi-vehicle crash in Jurupa Valley. The fatal accident occurred on the morning of January 9 on Van Buren Boulevard.

Four vehicles collided on Van Buren Boulevard, near Studio Place. One driver, an unidentified man, died at the accident scene. Two drivers stopped at the scene. A fourth driver fled the accident scene and left behind a flatbed trailer. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Jurupa Valley

#92509


October 4, 2019

Motorcyclist Injured in Crash on Highland Valley Road

Motorcycle, Tow Truck Collide in Ramona Accident Ramona, CA (October 3, 2019) ...


March 13, 2020

Woman Killed in Crash on Knabe Road

Motorcycle, Car Collide in Fatal Los Angeles Accident ...


April 1, 2020

Pedestrian Injured in Crash on Madison Avenue

Victim Hit by Car in Sacramento Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.